The Forum on Neuroscience and Nervous System Disorders hosted a public session at the 2011 Alzheimer's Association International Conference to identify a set of core principles that could be used to ...
Although phosphorylated tau at threonine 231 (pTau 231) is a promising blood-based biomarker for incipient Alzheimer's ...
The field of Alzheimer’s disease (AD) research has evolved significantly, shifting from a sole reliance on clinical diagnosis to an integrated approach ...
Alzheimer’s disease is diagnosed with multiple types of tests that also help to rule out other possible conditions with similar symptoms. You may have blood and urine tests, memory function tests, and ...
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached ...
Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results